6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs

Journal of Pharmaceutical Sciences

Volumn 100, Issue 9, 2011, Pages 3773-3782

  Lee, Na young ^a   Sai, Yoshimichi ^b   Nakashima, Emi ^c   Ohtsuki, Sumio ^d   Kang, Young sook ^a  

^a Sookmyung Women's University   (South Korea)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Drug transport; In vitro models; Multidrug resistance associated proteins; Nucleoside transporters; Organic anion transporters; Pharmacokinetics; Placenta

Indexed keywords

ADENOSINE; AZATHIOPRINE; CARBON 14; CEFMETAZOLE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; MERCAPTOPURINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; PROBENECID; SULFINPYRAZONE; TIOGUANINE; URIDINE;

ANIMAL CELL; ARTICLE; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ELIMINATION; DRUG MECHANISM; DRUG TRANSPORT; DRUG UPTAKE; MICHAELIS CONSTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SYNCYTIOTROPHOBLAST;

EID: 79960136319     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22631     Document Type: Article

References (32)

1. Fitzgerald C, Zimon AE, Jones EE. 1998. Aging and reproductive potential in women. Yale J Biol Med 71:367-381.
2. Yancik R, Ries LA. 1994. Cancer in older persons. Magnitude of the problem-How do we apply what we know? Cancer 74:1995-2003.
3. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. 2003. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: A retrospective cohort study. Gastroenterology 124:9-17.
4. Matalon ST, Ornoy A, Lishner M. 2004. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Reprod Toxicol 18:219-230.
5. Nørgård B, Pedersen L, Christensen LA, Sørensen HT. 2007. Therapeutic drug use in women with Crohn's disease and birth outcomes: A Danish nationwide cohort study. Am J Gastroenterol 102:1406-1413.
6. Kitano T, Iizasa H, Hwang IW, Hirose Y, Morita T, Maeda T, Nakashima E. 2004. Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood-placenta barrier. Biol Pharm Bull 27:753-759.
7. Saarikoski S, Seppala M. 1973. Immunosuppression during pregnancy: Transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 115:1100-1106.
8. Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, Fridland A. 1999. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 5:1048-1051.
9. Mori S, Ohtsuki S, Takanaga H, Kikkawa T, Kang YS, Terasaki T. 2004. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J Neurochem 90:931-941.
10. Hosoya K, Makihara A, Tsujikawa Y, Yoneyama D, Mori S, Terasaki T, Akanuma S, Tomi M, Tachikawa M. 2009. Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine. J Pharmacol Exp Ther 329:87-93.
11. Yao SY, Ng AM, Vickers MF, Sundaram M, Cass CE, Baldwin SA, Young JD. 2002. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem 277:24938-24948.
12. Nagai K, Nagasawa K, Kihara Y, Okuda H, Fujimoto S. 2007. Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2. Int J Pharm 333:56-61.
13. Nishimura M, Naito S. 2005. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 20:452-477.
14. Kitano T, Iizasa H, Terasaki T, Asashima T, Matsunaga N, Utoguchi N, Watanabe Y, Obinata M, Ueda M, Nakashima E. 2002. Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs. J Cell Physiol 193:208-218.
15. Lee NY, Choi HM, Kang YS. 2009. Choline transport via choline transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT. Placenta 30:368-374.
16. Lee NY, Kang YS. 2010. The inhibitory effect of rivastigmine and galantamine on choline transport in brain capillary endothelial cells. Biomol Ther 18:65-70.
17. Higuchi K, Iizasa H, Sai Y, Horieya S, Lee KE, Wada M, Deguchi M, Nishimura T, Wakayama T, Tamura A, Tsukita S, Kose N, Kang YS, Nakashima E. 2010. Differential expression of ezrin and CLP36 in the two layers of syncytiotrophoblast in rats. Biol Pharm Bull 33:1400-1406.
18. Chishu T, Sai Y, Nishimura T, Sato K, Kose N, Nakashima E. 2008. Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1. Placenta 29:461-467.
19. Sato K, Sai Y, Nishimura T, Chishu T, Shimpo S, Kose N, Nakashima E. 2009. Influx mechanism of 2′, 3′-dideoxyinosine and uridine at the blood-placenta barrier. Placenta 30:263-269.
20. Sai Y, Nishimura T, Shimpo S, Chishu T, Sato K, Kose N, Terasaki T, Mukai C, Kitagaki S, Miyakoshi N, Kang YS, Nakashima E. 2008. Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT. Pharm Res 25:1647-1653.
21. Ritter CA, Jedlitschky G, Meyer zu Schwabedissen H, Grube M, Köck K, Kroemer HK. 2005. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev 37:253-278.
22. Ward JL, Sherali A, Mo ZP, Tse CM. 2000. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275:8375-8381.
23. Govindarajan R, Bakken HA, Hudkins KL, Lai Y, Casado FJ, Pastor-Anglada M, Tse CM, Hayashi J, Unadkat JD. 2007. In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta. Am J Physiol Regul Integr Comp Physiol 293:R1809-R1822.
24. Wijnholds J, Mol CA, van Deemter, L de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P. 2000. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A 97:7476-7481.
25. Wielinga PR, Reid G, Challa EE, van der Heijden I, van Deemter L, de Haas M, Mol C, Kuil AJ, Groeneveld E, Schuetz JD, Brouwer C, De Abreu RA, Wijnholds J, Beijnen JH, Borst P. 2002. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol 62:1321-1331.
26. Leazer TM, Klaassen CD. 2003. The presence of xenobiotic transporters in rat placenta. Drug Metab Dispos 31:153-167.
27. St-Pierre MV, Serrano MA, Macias RI, Dubs U, Hoechli M, Lauper U, Meier PJ, Marin JJ. 2000. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279:R1495-R1503.
28. Nagashige M, Ushigome F, Koyabu N, Hirata K, Kawabuchi M, Hirakawa T, Satoh S, Tsukimori K, Nakano H, Uchiumi T, Kuwano M, Ohtani H, Sawada Y. 2003. Basal membrane localization of MRP1 in human placental trophoblast. Placenta 24:951-958.
29. Meyer ZU, Schwabedissen HE, Grube M, Heydrich B, Linnemann K, Fusch C, Kroemer HK, Jedlitschky G. 2005. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: Effects of gestational age and cellular differentiation. Am J Pathol 166:39-48.
30. Zeng H, Lin ZP, Sartorelli AC. 2004. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06. Biochem Pharmacol 68:911-921.
31. de Wolf C, Jansen R, Yamaguchi H, de Haas M, van de Wetering K, Wijnholds J, Beijnen J, Borst P. 2008. Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides. Mol Cancer Ther 7:3092-3102.
32. Treon SP, Chabner BA. 1996. Concepts in use of high-dose methotrexate therapy. Clin Chem 42:1322-1329.